Quick answers
- What is Pindolol used for?
- The FDA-approved label (Pindolol, PD-Rx Pharmaceuticals, Inc., July 17, 2026) says: “Pindolol tablets are indicated in the management of hypertension. It may be used alone or concomitantly with other antihypertensive agents, particularly with a thiazide-type diuretic.” This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
- Does Pindolol have a boxed warning?
- No. None of the 11 FDA labels we found for this medicine has a boxed warning.
- Is there a shortage of Pindolol?
- The FDA drug shortage list shows “To be discontinued” for a product of this medicine (updated January 30, 2026). Ask your pharmacist about alternatives.
- Has Pindolol been recalled?
- No recall linked to the products of this medicine appears in the FDA enforcement reports we use.
- Who makes Pindolol?
- 8 companies list prescription products of Pindolol in the FDA NDC Directory, including PD-Rx Pharmaceuticals, Inc., Bryant Ranch Prepack and Marlex Pharmaceuticals, Inc..
What Pindolol is used for
Quoted from the “Indications and Usage” section of the FDA-approved label.
Pindolol tablets are indicated in the management of hypertension. It may be used alone or concomitantly with other antihypertensive agents, particularly with a thiazide-type diuretic.
— FDA label: Pindolol, PD-Rx Pharmaceuticals, Inc., effective July 17, 2026. Read the full label on DailyMed →
The FDA has 11 labels for products of this medicine (different makers and forms); uses can differ between them. Check the label that comes with your own medicine.
This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
Conditions named on the label
These condition names appear word for word in the label’s “Indications and Usage” text (matched with a reviewed table). Each page lists hospitals whose own websites name the condition.
Related medical specialties
Boxed warning
A boxed warning (“black box”) is the FDA’s strongest warning on a drug label, for serious or life-threatening risks.
The label quoted above has no boxed warning.
0 of 11 FDA labels for this medicine have a boxed warning.
Forms and how it is given
| Dosage forms | Tablet |
|---|---|
| Route | Oral |
| Prescription products | 19 in the FDA NDC Directory |
What pharmacies pay (NADAC)
The National Average Drug Acquisition Cost (NADAC) is the average price U.S. retail pharmacies paid to buy one unit of a medicine (one tablet, one mL or one gram), from a monthly survey of pharmacy invoices by the Centers for Medicare & Medicaid Services (CMS). State Medicaid programs use it to pay pharmacies.
This is not the price you pay. What you pay depends on your insurance (copay or coinsurance), your pharmacy and any discounts, and pharmacies also charge for filling a prescription. Ask your pharmacist or your health plan what your price will be.
| Strength and form | Generic or brand | Pharmacies pay |
|---|---|---|
| pindolol 10 mg tablet | Generic | $0.8235 per tablet |
| pindolol 5 mg tablet | Generic | $0.5559 per tablet |
NADAC list of November 4, 2026; these prices took effect on October 21, 2026. Shown only where a package’s NDC code matches the NADAC list exactly, and only for that exact strength and form: nothing is averaged across strengths. Strengths and forms not listed here have no NADAC price.
Source: NADAC (National Average Drug Acquisition Cost) 2026, data.medicaid.gov (CMS) →
Companies that list this medicine
Labelers in the FDA NDC Directory: the company named on the package (maker or distributor), with the number of prescription products.
- PD-Rx Pharmaceuticals, Inc.4 products
- Bryant Ranch Prepack3 products
- Marlex Pharmaceuticals, Inc.2 products
- Sun Pharmaceutical Industries, Inc.2 products
- Westminster Pharmaceuticals, LLC2 products
- Proficient Rx LP2 products
- ANI Pharmaceuticals, Inc.2 products
- Unichem Pharmaceuticals (USA), Inc.2 products
FDA approval history
- ANDA: Abbreviated New Drug Application: how a generic version is approved.
Generic approvals (4)
- ANDA073609Ani Pharms · March 29, 1993
- ANDA074063Sun Pharm Industries · January 27, 1994
- ANDA205415Mpp Pharma · January 13, 2016
- ANDA211712Unichem · August 1, 2019
Shortage status
To be discontinued · updated January 30, 2026 · first posted January 30, 2026
| Product | Pindolol, Tablet, 10 mg (NDC 57664-656-88) |
|---|---|
| Company | Sun Pharmaceutical Industries, Inc. |
Ask your pharmacist whether your product is affected and what the options are.
Recalls
No recall linked to these products (by their NDC code) appears in the FDA enforcement reports.
Official identifiers
| RxCUI (RxNorm) | 198104, 198105 |
|---|---|
| SPL set ID of the quoted label | 0daed7b3-6017-4611-8c3a-2f390470f8bc |
| FDA labels (SPL) | 11 |
| FDA applications | 4 ANDA |
| Active ingredients (FDA) | PINDOLOL |
Sources
- FDA-approved label on DailyMed (National Library of Medicine) — Pindolol, PD-Rx Pharmaceuticals, Inc., effective July 17, 2026; via openFDA, FDA data exported October 30, 2026, retrieved October 31, 2026
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- Drug shortages (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
openFDA data is provided by the FDA as is; it may be incomplete. Always rely on the label that comes with your medicine. FDA Enforcement Report search →